Fundraising Fox

Metera Pharmaceuticals

Somerville, US · Founded 2016 · Delaware corporation

Founders & leadership

MC
Meredith C. Fisher, Ph.D.Named on SEC filing
ML
Marc Lenburg, Ph.D.Named on SEC filing

Reported raises · per SEC filings

Form D private placements

$8.6M disclosed across 1 round · 2016

$8.6MraisedJun 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Meredith C. Fisher, Ph.D.Director
  • Marc Lenburg, Ph.D.Executive Officer, Director
Offering amount
$8.6M
Amount sold
$8.6M
First sale
Dec 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$1.5M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

How much funding has Metera Pharmaceuticals raised?
Metera Pharmaceuticals has disclosed $8.6M raised across 1 round.
Where is Metera Pharmaceuticals headquartered?
Metera Pharmaceuticals is headquartered in Somerville, US.